ATE457030T1 - Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen - Google Patents

Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen

Info

Publication number
ATE457030T1
ATE457030T1 AT05763123T AT05763123T ATE457030T1 AT E457030 T1 ATE457030 T1 AT E457030T1 AT 05763123 T AT05763123 T AT 05763123T AT 05763123 T AT05763123 T AT 05763123T AT E457030 T1 ATE457030 T1 AT E457030T1
Authority
AT
Austria
Prior art keywords
hpv
host cell
cell proteins
vaccine
peptides
Prior art date
Application number
AT05763123T
Other languages
English (en)
Inventor
Stephen Tze Kwung Man
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cardiff filed Critical Univ Cardiff
Application granted granted Critical
Publication of ATE457030T1 publication Critical patent/ATE457030T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Liquid Crystal (AREA)
  • Magnetic Heads (AREA)
AT05763123T 2004-08-05 2005-07-27 Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen ATE457030T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417430.6A GB0417430D0 (en) 2004-08-05 2004-08-05 A novel HPV vaccine comprising peptides from host cell proteins
PCT/GB2005/002962 WO2006013336A1 (en) 2004-08-05 2005-07-27 Hpv vaccine comprising peptides from host cell proteins

Publications (1)

Publication Number Publication Date
ATE457030T1 true ATE457030T1 (de) 2010-02-15

Family

ID=32982559

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05763123T ATE457030T1 (de) 2004-08-05 2005-07-27 Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen

Country Status (10)

Country Link
US (2) US7538183B2 (de)
EP (1) EP1773876B1 (de)
JP (1) JP2008508873A (de)
CN (1) CN101027317B (de)
AT (1) ATE457030T1 (de)
AU (1) AU2005268646B2 (de)
CA (1) CA2575610C (de)
DE (1) DE602005019238D1 (de)
GB (1) GB0417430D0 (de)
WO (1) WO2006013336A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI441648B (zh) * 2007-01-03 2014-06-21 Oncotherapy Science Inc Ｆｏｘｐ３胜肽疫苗
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
CN102234688A (zh) * 2010-04-30 2011-11-09 北京心意圆成生物科技有限公司 一种哺乳动物细胞dna快速定量检测方法
CA2876656C (en) 2012-06-15 2023-09-26 Pds Biotechnology Corporation Cationic lipid vaccine compositions and methods of use
NZ718283A (en) 2013-09-25 2022-05-27 Cytomx Therapeutics Inc Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
US9562073B2 (en) 2014-01-31 2017-02-07 Cytomx Therapeutics, Inc. Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
CN107001430A (zh) 2014-10-24 2017-08-01 哈普威克斯有限责任公司 癌症和皮肤病变治疗
US10799574B2 (en) 2014-10-24 2020-10-13 Hpvvax. Llc Method and composition for treating cancer or skin lesion using a vaccine
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
SG11201811442UA (en) 2016-06-20 2019-01-30 Isa Pharmaceuticals B V Formulation of a peptide vaccine
EP3522908A4 (de) * 2016-10-05 2020-06-24 PDS Biotechnology Corporation Neuartige hpv16-nicht-hla-beschränkte t-zell-impfstoffe, zusammensetzungen und verfahren zur verwendung davon
WO2019113200A1 (en) 2017-12-05 2019-06-13 Pds Biotechnology Corporation Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes
CA3120327A1 (en) 2018-12-06 2020-06-11 Cytomx Therapeutics, Inc. Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof
US20240043476A1 (en) * 2020-10-28 2024-02-08 National University Corporation Hokkaido University Anti-tumor peptide and use thereof
WO2024223299A2 (en) 2023-04-26 2024-10-31 Isa Pharmaceuticals B.V. Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183746B1 (en) * 1997-10-09 2001-02-06 Zycos Inc. Immunogenic peptides from the HPV E7 protein
DE19859486A1 (de) * 1998-12-22 2000-07-06 Razvan Tudor Radulescu Peptide mit besonderen antiproliferativen Eigenschaften
US6440696B1 (en) * 1999-07-28 2002-08-27 New England Medical Center E6 targeted protein (E6TP1)
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
FR2839072A1 (fr) * 2002-04-24 2003-10-31 Neovacs Produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, composition immunogene contenant ledit produit d'expression et son procede de preparation
WO2004013631A2 (en) * 2002-07-29 2004-02-12 Mtm Laboratories Ag Compositions and methods for diagnosis and therapy of cancer
EP1553966B1 (de) * 2002-10-03 2012-08-01 Wyeth Holdings Corporation Fusionsproteine bestehend aus den humanen papillomavirus E7 und E6 Proteinen sowie immunogene Zusammensetzungen davon

Also Published As

Publication number Publication date
EP1773876A1 (de) 2007-04-18
US7538183B2 (en) 2009-05-26
AU2005268646A1 (en) 2006-02-09
GB0417430D0 (en) 2004-09-08
US20070218074A1 (en) 2007-09-20
DE602005019238D1 (de) 2010-03-25
AU2005268646A2 (en) 2006-02-09
US20090232842A1 (en) 2009-09-17
WO2006013336A1 (en) 2006-02-09
AU2005268646B2 (en) 2011-01-06
WO2006013336A9 (en) 2007-03-29
HK1097279A1 (en) 2007-06-22
CN101027317B (zh) 2013-01-30
EP1773876B1 (de) 2010-02-03
CA2575610A1 (en) 2006-02-09
JP2008508873A (ja) 2008-03-27
CN101027317A (zh) 2007-08-29
CA2575610C (en) 2014-02-11

Similar Documents

Publication Publication Date Title
ATE457030T1 (de) Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen
Vande Pol et al. Papillomavirus E6 oncoproteins
AR077396A2 (es) EXPRESIoN OPTIMIZADA DE LA PROTEíNA DE LA CÁPSIDE L1 DEL VIRUS DE PAPILOMA HUMANO VPH45 EN LEVADURAS
MY139500A (en) Optimized expression of hpv 58 l1 in yeast
WO2010149752A3 (en) Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease
TR201908199T4 (tr) HPV'ye karşı aşılar.
DE602007009941D1 (de) Immunogene peptide und verwendungsverfahren dafür
EP3584251A3 (de) Hpv-epitope als ziel für zervikale tumoren infiltrierende t-zellen zur verwendung bei impfstoffen
ATE546529T1 (de) Optimierte expression von hpv 31 l1 in hefe
EP1563074A4 (de) Adenovirusvektor-impfstoff
EP1917033A4 (de) Virusähnliche partikel als paramyxovirus-impfstoffe
MX379069B (es) Vacunas terapeuticas contra el vph16.
NZ745324A (en) Vaccines and vaccine components for inhibition of microbial cells
DK1968632T3 (da) Forbedret influenzavaccine
JOP20210186A1 (ar) مستضدات البروستاتا المستحدثة واستخداماتها
IN2013CN00536A (de)
BRPI0909547A2 (pt) vacina combinada de sarampo - hpv, vetor e hospedero
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2007008918A3 (en) Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof
DK1290160T3 (da) Humane Pellino-polypeptider
NZ606949A (en) Human papillomavirus e7 antigen compositions and uses thereof
TW200637573A (en) Peptide for delivery of mucosal vaccines
AU2003260452A1 (en) Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
UA98254C2 (ru) мукозальная вакцина для иммунотерапии заболеваний, обусловленных вирусами папилломы человека
PL1716169T3 (pl) Podjednostkowe szczepionki przeciwko Ornithobacterium rhinotracheale

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties